Post job

Skyhawk Therapeutics's revenue is $580,000.

What is Skyhawk Therapeutics's revenue?

Skyhawk Therapeutics's annual revenue is $580.0K. Zippia's data science team found the following key financial metrics about Skyhawk Therapeutics after extensive research and analysis.
  • Skyhawk Therapeutics has 30 employees, and the revenue per employee ratio is $19,333.
  • Skyhawk Therapeutics peak revenue was $580.0K in 2024.

On this page

Peak revenue
$580,000 (2024)
Company peak revenue
Revenue / employee
$19,333
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$580,000 (2024)
Company peak revenue
Revenue / employee
$19,333
Company revenue / employee

Skyhawk Therapeutics financing

Skyhawk Therapeutics received early financing of $203.0K on 2017-02-24.

SeriesRound sizeDate
Convertible Note$203K02/2017
Seed$8M01/2018
Series Unknown$40M06/2018
Series Unknown$133M09/2021

Skyhawk Therapeutics investors

InvestorsSecurity type
Good Growth CapitalConvertible Note
Tim DisneySeed
The Duke of BedfordSeed
Alexandria Venture InvestmentsSeed
GreatPoint VenturesSeries Unknown
Tim DisneySeries Unknown
CELGENE CORP /DE/Series Unknown
Agent CapitalSeries Unknown
The Duke of BedfordSeries Unknown
ShangPharma Innovation IncSeries Unknown
Alexandria Venture InvestmentsSeries Unknown
FmrSeries Unknown

Skyhawk Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Skyhawk Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Skyhawk Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Skyhawk Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Skyhawk Therapeutics. The data presented on this page does not represent the view of Skyhawk Therapeutics and its employees or that of Zippia.

Skyhawk Therapeutics may also be known as or be related to Skyhawk Therapeutics and Skyhawk Therapeutics, Inc.